Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker

Laboratory Investigation

Volumn 78, Issue 10, 1998, Pages 1315-1325

  Rubio, Nuria ^a   Villacampa, Mercedes Martinez ^a,b   Blanco, Jerónimo ^a,c  

^a Institut de Recerca Oncologica   (Spain)

^b CSIC   (Spain)

^c DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; LUCIFERASE; TUMOR MARKER;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CONTROLLED STUDY; GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LYMPH NODE; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; TUMOR CELL; TUMOR GROWTH;

ANIMALS; CELL LINE; GENES, REPORTER; HUMANS; LUCIFERASES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; REGRESSION ANALYSIS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0344836018     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Smith JA, Siedman JG, and Struhl K (1995). Preparation of genomic DNA from mammalian tissue. In: Current protocols in molecular biology. New York: John Wiley and Sons, 2.2.1-2.2.3.
2. Campbell A and Sala-Newby G (1996). Bioluminescent and chemiluminescent indicators for molecular signalling and function in living cells. In: Mason WT, editor: Fluorescent and luminescent probes for biological activity. New York: Academic Press, 58-82.
3. Chishima T, Miyagi Y, Wang X, Baranov E, Tan Y, Shimada H, Moossa AR, and Hoffman RM (1997). Metastatic patterns of lung cancer visualized live and in process by green fluorescence protein expression. Clin Exp Metastasis 15:547-552.
4. Cote RJ, Rosen PP, Hakes TB, Sedina M, Bazinet M, Kinne DW, Old LJ, and Osborne MP (1988). Monoclonal antibodies detect occult breast carcinoma metastases in the bone marrow of patients with early stage disease. Am J Surg Pathol 12:333-340.
5. Crowley CW, Cohen RL, Lucas BK, Lin G, Shuman MA, and Levison AD (1993). Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A 90:5021-5025.
6. de Wet JR, Wood KV, DeLuca M, Helinski DR, and Subramani S (1987). Firefly luciferase gene: Structure and expression in mammalian cells. Mol Cell Biol 7:725-737.
7. Dingemans A-MC, Brakenhoff RH, Postmus PE, and Giaccone G (1997). Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients. Lab Invest 77:213-220.
8. Gao AC, Lou W, Dong JT, and Issacs JT (1997). CD44 is a metastasis suppressor gene for prostatic cancer located in human chromosome 11p13. Cancer Res 57:846-849.
9. Gittes RF (1991). Carcinoma of the prostate. N Engl J Med 324:236-245.
10. Hanks EH, Myers CE, and Scardino PT (1993). Cancer of the prostate. In: DeVita VT Jr, Hellman S, and Rosenberg SA, editors: The principles and practice of oncology. Philadelphia: J.B. Lippincott Co., 1073-1085.
11. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, and Jones LW (1979). Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17:16-23.
12. Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, and Hart IR (1984). Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44:3522-3529.
13. Kruger A, Umansky V, Rocha M, Hacker HJ, Schirrmacher V, and von Hoegen P (1994). Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma. Blood 84:3166-3174.
14. Kurebayashi J, McLeskey SW, Johnson MD, Lippman ME, Dickson RB, and Kern FG (1993). Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and lacZ. Cancer Res 53:2178-2187.
15. Matano S, Ryoyama K, Nakamura S, Okada G, and Nomura T (1995). Application of the polymerase chain reaction (PCR) to quantify micro-metastasis in an experimental animal. Cancer Lett 91:93-99.
16. Mattano LA, Moss TJ, and Emerson SG (1992). Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase polymerase chain reaction. Cancer Res 52:4701-4705.
17. Moreno JG, Croce CM, Fischer R, Monne M, Wihko P, Mulholland SG, and Gomella LG (1992). Detection of haematogenous micrometastasis in patients with prostate cancer. Cancer Res 52:6110-6112.
18. Morikawa K, Walker SM, Nakajima M, Pathak S, Jessup JM, and Fidler IJ (1988). Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48:6863-6871.
19. Nawroz H, Koch W, Anker P, Stroun M, and Sidransky D (1996). Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2:1035-1037.
20. Nicolson GL (1993). Cancer progression and growth: Relationship of paracrine and autocrine growth mechanisms to organ preference of metastases. Exp Cell Res 204:171-180.
21. O'Connor KL and Culp LA (1994). Quantitation of two histochemical markers in the same extract using chemiluminescent substrates. Biotechniques 17:502-506.
22. Osborne M, Wong GY, Asina S, Old LJ, Cote RJ, and Rosen PP (1991). Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res 51:2706-2709.
23. Overton WR (1988). Modified histogram substraction technique for analysis of flow cytometry data. Cytometry 9:619-626.
24. Pantel K, Izbiccki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, and Riethmuller G (1996). Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347:649-653.
25. Parke SL, Tong T, Bolden S, and Wingo PA (1996). Cancer statistics. CA Cancer J Clin 47:5-27.
26. Radinsky R and Fidler IJ (1992). Regulation of tumor cell growth at organ-specific metastases. In Vivo 6:325-331.
27. Rose WC (1981). Evaluation of Madison 109 lung carcinoma as a model for screening antitumor drugs. Cancer Treat Rev 65:299-312.
28. Rubio N and Blanco J (1996). Simultaneous selection and cloning of transfected eukaryotic cells. Biotechniques 21: 622-624.
29. Smith C, Muench MO, Knizewski M, Gilboa E, and Moore MA (1993). Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia. Leukemia 7:310-317.
30. Southern PJ and Berg P (1982). Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV-40 early region promoter. J Mol Appl Genet 1:327-341.
31. Stephenson RA, Dinney CP, Gohji K, Ordoñez NG, Killion JJ, and Fidler IJ (1992). Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 84:951-957.
32. Zeidman I, McCutcheon M, and Coman DR (1950). Factors affecting the number of tumor metastasis, experiments with a transplantable mouse tumor. Cancer Res 10:357-361.
33. Zhang L, Hellstrom KE, and Chen L (1994). Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin Exp Metastasis 12:87-92.